Effects of blood storage age on immune, coagulation, and nitric oxide parameters in transfused patients undergoing cardiac surgery.
Journal
Transfusion
ISSN: 1537-2995
Titre abrégé: Transfusion
Pays: United States
ID NLM: 0417360
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
22
10
2018
revised:
13
12
2018
accepted:
15
12
2018
pubmed:
6
3
2019
medline:
20
5
2020
entrez:
6
3
2019
Statut:
ppublish
Résumé
Retrospective studies suggested that storage age of RBCs is associated with inflammation and thromboembolism. The Red Cell Storage Duration Study (RECESS) trial randomized subjects undergoing complex cardiac surgery to receive RBCs stored for shorter versus longer periods, and no difference was seen in the primary outcome of change in multiple organ dysfunction score. In the current study, 90 subjects from the RECESS trial were studied intensively using a range of hemostasis, immunologic, and nitric oxide parameters. Samples were collected before transfusion and on Days 2, 6, 28, and 180 after transfusion. Of 71 parameters tested, only 4 showed a significant difference after transfusion between study arms: CD8+ T-cell interferon-γ secretion and the concentration of extracellular vesicles bearing the B-cell marker CD19 were higher, and plasma endothelial growth factor levels were lower in recipients of fresh versus aged RBCs. Plasma interleukin-6 was higher at Day 2 and lower at Days 6 and 28 in recipients of fresh versus aged RBCs. Multiple parameters showed significant modulation after surgery and transfusion. Most analytes that changed after surgery did not differ based on transfusion status. Several extracellular vesicle markers, including two associated with platelets (CD41a and CD62P), decreased in transfused patients more than in those who underwent surgery without transfusion. Transfusion of fresh versus aged RBCs does not result in substantial changes in hemostasis, immune, or nitric oxide parameters. It is possible that transfusion modulates the level of platelet-derived extracellular vesicles, which will require study of patients randomly assigned to receipt of transfusion to define.
Sections du résumé
BACKGROUND
Retrospective studies suggested that storage age of RBCs is associated with inflammation and thromboembolism. The Red Cell Storage Duration Study (RECESS) trial randomized subjects undergoing complex cardiac surgery to receive RBCs stored for shorter versus longer periods, and no difference was seen in the primary outcome of change in multiple organ dysfunction score.
STUDY DESIGN AND METHODS
In the current study, 90 subjects from the RECESS trial were studied intensively using a range of hemostasis, immunologic, and nitric oxide parameters. Samples were collected before transfusion and on Days 2, 6, 28, and 180 after transfusion.
RESULTS
Of 71 parameters tested, only 4 showed a significant difference after transfusion between study arms: CD8+ T-cell interferon-γ secretion and the concentration of extracellular vesicles bearing the B-cell marker CD19 were higher, and plasma endothelial growth factor levels were lower in recipients of fresh versus aged RBCs. Plasma interleukin-6 was higher at Day 2 and lower at Days 6 and 28 in recipients of fresh versus aged RBCs. Multiple parameters showed significant modulation after surgery and transfusion. Most analytes that changed after surgery did not differ based on transfusion status. Several extracellular vesicle markers, including two associated with platelets (CD41a and CD62P), decreased in transfused patients more than in those who underwent surgery without transfusion.
CONCLUSIONS
Transfusion of fresh versus aged RBCs does not result in substantial changes in hemostasis, immune, or nitric oxide parameters. It is possible that transfusion modulates the level of platelet-derived extracellular vesicles, which will require study of patients randomly assigned to receipt of transfusion to define.
Identifiants
pubmed: 30835880
doi: 10.1111/trf.15228
pmc: PMC8336068
mid: NIHMS1728118
doi:
Substances chimiques
Antigens, CD
0
IL6 protein, human
0
Interleukin-6
0
Nitric Oxide
31C4KY9ESH
Types de publication
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1209-1222Subventions
Organisme : NIGMS NIH HHS
ID : R01 GM113838
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL095470
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL072268
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL072268-09S1
Pays : United States
Informations de copyright
© 2019 AABB.
Références
Am J Respir Crit Care Med. 2012 Apr 15;185(8):842-50
pubmed: 22281833
JAMA. 1993 Jun 16;269(23):3024-9
pubmed: 8501845
Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2531-6
pubmed: 15699345
J Clin Invest. 2007 Sep;117(9):2592-601
pubmed: 17786245
Transfusion. 2004 Nov;44(11):1626-34
pubmed: 15504169
Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17058-62
pubmed: 17940022
Circ Res. 2005 May 27;96(10):1119-26
pubmed: 15879309
Cell. 2004 Feb 20;116(4):617-28
pubmed: 14980227
Diabetologia. 2002 Nov;45(11):1515-22
pubmed: 12436334
Transfusion. 2012 Dec;52(12):2533-50
pubmed: 22452342
Methods. 2013 Aug 1;62(2):123-9
pubmed: 23116707
Transfusion. 2006 Jul;46(7):1120-9
pubmed: 16836558
Transfusion. 2011 Nov;51(11):2286-94
pubmed: 21564106
Crit Care Med. 2008 Apr;36(4):1290-6
pubmed: 18379257
Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17063-8
pubmed: 17940021
Science. 1997 Jun 27;276(5321):2034-7
pubmed: 9197264
Blood. 2006 Nov 1;108(9):3225-6; author reply 3226-7
pubmed: 17057023
Circ Res. 2004 Apr 16;94(7):976-83
pubmed: 14963010
J Trauma. 1987 Mar;27(3):243-9
pubmed: 3560265
J Lab Clin Med. 1969 May;73(5):722-33
pubmed: 5779258
Proc Natl Acad Sci U S A. 2005 Apr 19;102(16):5709-14
pubmed: 15824313
N Engl J Med. 2015 Apr 9;372(15):1419-29
pubmed: 25853746
Annu Rev Physiol. 2005;67:99-145
pubmed: 15709954
Circulation. 2004 Mar 23;109(11):1339-42
pubmed: 15023874
Nature. 1996 Mar 21;380(6571):221-6
pubmed: 8637569
Eur J Cardiothorac Surg. 2011 Mar;39(3):329-34
pubmed: 20702101
Pathophysiol Haemost Thromb. 2003;33(1):4-15
pubmed: 12853707
Transfus Apher Sci. 2008 Apr;38(2):141-7
pubmed: 18346937
Transfus Med. 2011 Jun;21(3):150-7
pubmed: 21198999
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 May 15;851(1-2):140-51
pubmed: 17379583
Surg Gynecol Obstet. 1970 Oct;131(4):733-41
pubmed: 5458535
Vox Sang. 2013 Jul;105(1):11-7
pubmed: 23347295
N Engl J Med. 2008 Mar 20;358(12):1229-39
pubmed: 18354101
Compr Physiol. 2011 Jan;1(1):541-68
pubmed: 23737185
Transfusion. 2013 Aug;53(8):1744-54
pubmed: 23228139
Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14801-6
pubmed: 16203976
Blood. 2004 Sep 1;104(5):1375-82
pubmed: 15150083
Transfusion. 2009 Aug;49(8):1569-79
pubmed: 19413726
Br J Haematol. 1989 May;72(1):81-4
pubmed: 2786735
Lancet. 1954 Jan 16;266(6803):119-24
pubmed: 13118742
J Infect Dis. 2008 May 1;197(9):1296-306
pubmed: 18422442